Computational Prediction of Olea europaea Compounds as Inhibitor of Main-Peptidase of SARS-CoV2

Rashid Saif, Ghafran Ali, Kanza Ashfaq, Saeeda Zia, Abdul Rasheed Qureshi

Abstract


Background: In December 2019, Severe Acute Respiratory Syndrome Novel Coronavirus 2 (SARS-nCOV2) was identified as potential causative agent for COVID-19 in the Wuhan City of China. This disease spread around the whole globe, thus WHO declared it as a pandemic by March 11, 2020. Due to rapid mutation rate, lack of specific genomic knowledge and treatment modalities against this RNA based virus, world scientific community urges to work for vaccine production, treatments options and alternative remedies including eastern herbs as potential anti-viral agents.

Methods: Olea europaea (Olive) was found highly beneficial on the basis of its previous therapeutic applications. So, in the current study, its five different compounds (Catechin, Cynaroside, Elenolic Acid, Hydroxytyrosol, and Oleuropein) were chosen according to Lipinski physiochemical parameters, which were compared with already clinically used five anti-viral drugs (Ribavirin, Niclosamide, Nelfinavir, S-Nitroso-N-acetyl penicillamine, Chloroquine) against the Main-Peptidase (PDB ID:2GTB) of SARS-nCoV2 using Molecular Operating Environment (MOE) software.

Results: Among the chosen compounds of Olea europaea which were docked on the active site of Main-Peptidase, Oleuropein provide the best minimum binding energy of -8.3201kcal/mol followed by Cynaroside with -7.2121kcal/mol. These two energy complexes are considered to have better drug potential in this initial studies as compare to the already commercially used drug agents e.g. Chloroquine, Ribavirin, Niclosamide and S-Nitroso-N-acetyl Penicillamine having binding energy of -6.7168, -5.8171, -6.3361 and -5.4219kcal/mol respectively. Other three agents from olive were also docked to compare the binding energy of aforementioned clinically used drugs.

Conclusion: Oleuropein and Cynaroside are considered to be the most compelling compounds as a drug agent against coronavirus2 infection. Further, molecular dynamic simulations and in-vivo investigations are needed to endorse the current findings of these compounds as potential drugs.   

Keywords: Molecular Docking; SARS-nCoV2; 2 GTB; MOE software


Full Text:

PDF

References


Boopathi S, Poma AB, Kolandaivel PJJoBS, Dynamics. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. Journal of Biomolecular Structure and Dynamics, (2020); 1-10.

Ahmed SI, Hayat MQ, Tahir M, Mansoor Q, Ismail M, et al. Pharmacologically active flavonoids from the anticancer, antioxidant and antimicrobial extracts of Cassia angustifolia Vahl. BMC complementary and alternative medicine, (2016); 16(1): 460.

Benavente-Garcıa O, Castillo J, Lorente J, Ortuño A, Del Rio J. Antioxidant activity of phenolics extracted from Olea europaea L. leaves. Food chemistry, (2000); 68(4): 457-462.

Omar SH. Cardioprotective and neuroprotective roles of oleuropein in olive. Saudi Pharmaceutical Journal, (2010); 18(3): 111-121.

Gonzalez M, Zarzuelo A, Gamez M, Utrilla M, Jimenez J, et al. Hypoglycemic activity of olive leaf. Planta medica, (1992); 58(06): 513-515.

Bouchentouf S, Missoum N. Identification of Compounds from Nigella Sativa as New Potential Inhibitors of 2019 Novel Coronasvirus (Covid-19): Molecular Docking Study. (2020). Preprints 2020, 2020040079.

Molecular Operating Environment (MOE), 2019.01; Chemical Computing Group ULC, 1010 Sherbooke St. West, Suite #910, Montreal, QC, Canada, H3A 2R7, 2020

Charoenprasert S, Mitchell A. Factors influencing phenolic compounds in table olives (Olea europaea). Journal of Agricultural and Food Chemistry, (2012); 60(29): 7081-7095.

Artajo LS, Romero MP, Tovar MJ, Motilva MJ. Effect of irrigation applied to olive trees (Olea europaea L.) on phenolic compound transfer during olive oil extraction. European journal of lipid science and technology, (2006); 108(1): 19-27.

Lee T-W, Cherney MM, Huitema C, Liu J, James KE, et al. Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide. Journal of molecular biology, (2005); 353(5): 1137-1151.

Lipinski CAJDDTT. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies, (2004); 1(4): 337-341.

Chen X, Li H, Tian L, Li Q, Luo J, et al. Analysis of the Physicochemical Properties of Acaricides Based on Lipinski's Rule of Five.

Journal of computational biology, (2020); 27(9):1397-1406

Vilar S, Cozza G, Moro S. Medicinal chemistry and the molecular operating environment (MOE): application of QSAR and molecular docking to drug discovery. Current topics in medicinal chemistry, (2008); 8(18): 1555-1572.

Mattos C, Ringe D. Locating and characterizing binding sites on proteins. (2007), 1996; 14(5): 595-9.

da Silva Antonio A, Wiedemann LS, Veiga-Junior VF. Natural products' role against COVID-19. RSC Advances. (2020); 10(39): 23; 379-93.

Borges A, José H, Homem V, Simões M. Comparison of Techniques and Solvents on the Antimicrobial and Antioxidant Potential of Extracts from Acacia dealbata and Olea europaea. Antibiotics, (2020); 9(2):48.

Khaerunnisa S, Kurniawan H, Awaluddin R, Suhartati S, Soetjipto S. Potential inhibitor of COVID-19 main protease (Mpro) from several medicinal plant compounds by molecular docking study. Preprints, (2020); 13(20944): 1-4.

Maduka Tochukwu OD, Enyoh CE, JM IU. Potential Plants for Treatment and Management of COVID-19 in Nigeria. Academic Journal Chemistry, (2020); 5(6):69-80.




DOI: http://dx.doi.org/10.62940/als.v8i2.1040

Refbacks

  • There are currently no refbacks.